Product NewsClinical Diagnostics
Leqembi (lecanemab) is the first medicine that slows progression of early Alzheimer's disease to be authorized in the EU
For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)
View article